Benjamin David Novak’s corporate practice focuses on equity financings, debt financings, corporate governance, securities matters, and mergers and acquisitions. He represents emerging growth companies in the US and abroad in various industries including technology and life sciences, as well as, angel investors, private equity firms, and venture capital funds.
truly meets us where we are, gone above and beyond, and invested alongside us.
Ben is an active member of the startup and venture capital community. He serves on multiple Boards and Advisory Boards. Additionally, he routinely speaks at events, conferences, and universities on a variety of topics related to technology, entrepreneurship, and investing.
Outside of his role at Morgan Lewis, Ben is personally an active angel investor, who invests primarily in East Coast based seed stage technology companies. Prior to joining Morgan Lewis, Ben was an associate in the venture capital and technology practice of a prominent national law firm.
Flowonix Medical, a medical device manufacturer, in its $33 million Series B preferred stock financing
Upskill, formerly APX Labs, an augmented reality technology company, in its Convertible Debt financing led by New Enterprise Associates
101 Edu, an edtech software company, in its Series Seed Preferred Stock financing
Medcura, a clinical-stage life sciences company, in its Series Seed Preferred Stock financing
Untethered Labs, a cybersecurity hardware and software company, in its Series A Preferred Stock financing
Gridless Power, a cleantech hardware and software company, in its Series A-1 Preferred Stock financing
Videolicious, a video software company, in its Series E Preferred Stock financing
Inbox Health, a digitalhealth software company, in its Series Seed Preferred Stock financing
Flowonix Medical, a medical device manufacturer, in its Series BB financing
Theaprin Pharmaceuticals, a specialty pharmaceutical company, in its Common Stock financing
SeventySix Capital in its investment in Vegas Stats & Information Network, a sports betting media network providing news, analysis, and proprietary data
Mergers & Acquisitions
Aristech Surfaces, a producer of continuous cast acrylic sheets for the wellness, architectural, transportation, and industrial markets, in its $445 million sale to Trinseo
Corente, a software technology company, in its sale to Oracle
General Econopak, a manufacturer of sterility maintenance, barrier protection, and sterile cleanroom products, in its $175 million sale to Steris Corporation
SK Capital Partners in its acquisition of Tri-Tex, a global chemical company
A&E Medical, a medical device company, in its sale to Vance Street Capital
Richard Forman, the sole stockholder of Forman Mills, a retail chain and department store, in the sale of the company to Goode Partners
SK Capital Partners in the sale of its portfolio company, Calabrian, a producer of liquid sulfur dioxide, to INEOS Enterprises
College of William & Mary, Marshall-Wythe School of Law, 2010, J.D.
The College of New Jersey, 2007, B.S., Business Management, summa cum laude
District of Columbia
Awards and Affiliations
Recommended, M&A/corporate and commercial: Venture capital and emerging companies, The Legal 500 US (2022)
Ranked, Corporate/M&A, New Jersey, Chambers USA (2022)
Board Member, Angel Capital Association
Board Member and Chair of the Investors Committee, TechUnited
Board of Advisors Member, William & Mary Business Law Review
Digital Health Advisory Board Member, Philadelphia Alliance for Capital and Technologies
New Leader of the Bar, New Jersey Law Journal
Scholarship and Leadership Award, American Law Institute and American Bar Association
Staff Editor, William & Mary Bill of Rights Journal
Editor-in-Chief and Founder, William & Mary Business Law Review